274 related articles for article (PubMed ID: 25991737)
1. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.
Hwang H; Matsuo K; Duncan K; Pakzamir E; Pham HQ; Correa A; Fedenko A; Mhawech-Fauceglia P
J Clin Pathol; 2015 Sep; 68(9):710-7. PubMed ID: 25991737
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
[TBL] [Abstract][Full Text] [Related]
3. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
Chu PG; Arber DA; Weiss LM; Chang KL
Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
[TBL] [Abstract][Full Text] [Related]
4. IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma.
Zhao W; Cui M; Zhang R; Shen X; Xiong X; Ji X; Tao L; Jia W; Pang L; Sun Z; Wang C; Zou H
BMC Cancer; 2021 Sep; 21(1):1047. PubMed ID: 34556086
[TBL] [Abstract][Full Text] [Related]
5. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus].
Farah-Klibi F; Ben Hamouda S; Ben Romdhane S; Sfar R; Koubaa A; Ben Jilani S; Zermani R
J Gynecol Obstet Biol Reprod (Paris); 2008 Sep; 37(5):457-62. PubMed ID: 18565690
[TBL] [Abstract][Full Text] [Related]
7. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
[TBL] [Abstract][Full Text] [Related]
8. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma.
Rush DS; Tan J; Baergen RN; Soslow RA
Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075
[TBL] [Abstract][Full Text] [Related]
9. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus.
Busca A; Gulavita P; Parra-Herran C; Islam S
Int J Gynecol Pathol; 2018 Jul; 37(4):372-378. PubMed ID: 28700435
[TBL] [Abstract][Full Text] [Related]
10. Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma.
Davidson B; Hellesylt E; Holth A; Danielsen HE; Skeie-Jensen T; Katz B
Virchows Arch; 2017 Sep; 471(3):355-362. PubMed ID: 28643014
[TBL] [Abstract][Full Text] [Related]
11. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
[TBL] [Abstract][Full Text] [Related]
12. [The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma].
Zhu XQ; Shi YF; Cheng XD; Wu YZ
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1419-21. PubMed ID: 14521746
[TBL] [Abstract][Full Text] [Related]
13. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
14. Metastatic low-grade endometrial stromal sarcoma of uterus presenting as a primary pancreatic tumor: case presentation and literature review.
McCarthy AJ; Clarke BA; McGilvray I; Dickson BC; Khalili K; Chetty R
Diagn Pathol; 2019 Apr; 14(1):30. PubMed ID: 31010432
[TBL] [Abstract][Full Text] [Related]
15. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups.
Bartosch C; Exposito MI; Lopes JM
Int J Surg Pathol; 2010 Aug; 18(4):286-91. PubMed ID: 19482859
[TBL] [Abstract][Full Text] [Related]
16. The importance of CD10 and h-Caldesmon in the distinction of smooth muscle tumors of the uterus and endometrial stromal sarcoma.
Saraydaroglu O; Ozuysal S; Kasap M; Ozerkan K
Saudi Med J; 2008 Sep; 29(9):1349-50. PubMed ID: 18813428
[No Abstract] [Full Text] [Related]
17. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
[TBL] [Abstract][Full Text] [Related]
18. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
Yilmaz A; Rush DS; Soslow RA
Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
[TBL] [Abstract][Full Text] [Related]
19. [Endometrial stromal sarcoma: morphologic features and detection of JAZF1-SUZ12 and YWHAE FAM22 fusion genes].
Chang B; Lu LX; Tu XY; Cheng YF; Bi R; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):308-13. PubMed ID: 27142911
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma.
Agoff SN; Grieco VS; Garcia R; Gown AM
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):164-9. PubMed ID: 11396634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
